Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension

被引：0
|
作者：
Nazzareno Galiè
Sean Gaine
Richard Channick
J. Gerry Coghlan
Marius M. Hoeper
Irene M. Lang
Vallerie V. McLaughlin
Cheryl Lassen
Lewis J. Rubin
Shu-Fang Hsu Schmitz
Olivier Sitbon
Victor F. Tapson
Kelly M. Chin
机构：
[1] University of Bologna and IRCCS-S.Orsola University Hospital,Alma Mater Studiorum
[2] Mater Misericordiae University Hospital,David Geffen School of Medicine
[3] UCLA,undefined
[4] Royal Free Hospital,undefined
[5] Hannover Medical School and German Centre for Lung Research (DZL/BREATH),undefined
[6] Medical University of Vienna,undefined
[7] University of Michigan,undefined
[8] Actelion Pharmaceuticals Ltd,undefined
[9] University of California,undefined
[10] San Diego,undefined
[11] Hôpital Bicêtre,undefined
[12] Cedars-Sinai Medical Center,undefined
[13] University of Texas Southwestern Medical Center,undefined
[14] Université Paris-Sud,undefined
[15] INSERM Unité 999,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Selexipag; Pulmonary arterial hypertension; PAH; GRIPHON; Open-label extension; Safety; Tolerability; Survival; Combination therapy; Long-term outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：796 / 810
页数：14
相关论文
共 50 条
  • [41] Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis
    Ballard, Clive G.
    Kreitzman, David L.
    Isaacson, Stuart
    Liu, I-Yuan
    Norton, James C.
    Demos, George
    Fernandez, Hubert H.
    Ilic, Tihomir V.
    Azulay, Jean-Philippe
    Ferreira, Joaquim J.
    Abler, Victor
    Stankovic, Srdjan
    PARKINSONISM & RELATED DISORDERS, 2020, 77 : 100 - 106
  • [42] Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: Results from a phase III open-label extension trial
    Husain, Aatif
    Chung, Steve
    Faught, Edward
    Isojarvi, Jouko
    McShea, Cindy
    Doty, Pamela
    EPILEPSIA, 2012, 53 (03) : 521 - 528
  • [43] Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program
    Farnier, Michel
    Hovingh, G. Kees
    Langslet, Gisle
    Dufour, Robert
    Baccara-Dinet, Marie T.
    Din-Bell, Chantal
    Manvelian, Garen
    Guyton, John R.
    ATHEROSCLEROSIS, 2018, 278 : 307 - 314
  • [44] Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patients
    Tahara, Nobuhiro
    Dobashi, Hiroaki
    Fukuda, Keiichi
    Funauchi, Masanori
    Hatano, Masaru
    Ikeda, Satoshi
    Joho, Shuji
    Kihara, Yasuki
    Kondo, Takahisa
    Matsushita, Masakazu
    Minamino, Tohru
    Nakanishi, Norifumi
    Okano, Yoshiaki
    Ozaki, Yukio
    Saji, Tsutomu
    Sakai, Satoshi
    Tanabe, Nobuhiro
    Watanabe, Hiroshi
    Yamada, Hidehiro
    Yoshioka, Koichiro
    Hatta, Motonori
    Sasayama, Shigetake
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (06) : 921 - 928
  • [45] Real-world, long-term survival of incident patients with pulmonary arterial hypertension
    Marques-Alves, P.
    Baptista, R.
    Marinho da Silva, A.
    Pego, M.
    Castro, G.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2017, 23 (03) : 124 - 131
  • [46] Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: Interim results of an open-label extension study
    Ng, Yu-Tze
    Conry, Joan
    Paolicchi, Juliann
    Kernitsky, Lydia
    Mitchell, Wendy
    Drummond, Rebecca
    Isojarvi, Jouko
    Lee, Deborah
    Owen, Randall
    EPILEPSY & BEHAVIOR, 2012, 25 (04) : 687 - 694
  • [47] A long-term open-label safety study of galcanezumab in Japanese patients with migraine
    Hirata, Koichi
    Takeshima, Takao
    Sakai, Fumihiko
    Tatsuoka, Yoshihisa
    Suzuki, Norihiro
    Igarashi, Hisaka
    Nakamura, Tomomi
    Ozeki, Akichika
    Yamazaki, Hiroyoshi
    Skljarevski, Vladimir
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 721 - 733
  • [48] Long-term safety and durability of effect with a combination of olanzapine and samidorphan in patients with schizophrenia: results from a 1-year open-label extension study
    Yagoda, Sergey
    Graham, Christine
    Simmons, Adam
    Arevalo, Christina
    Jiang, Ying
    McDonnell, David
    CNS SPECTRUMS, 2021, 26 (04) : 383 - 392
  • [49] The bosentan patient registry: long-term survival in pulmonary arterial hypertension
    Keogh, A.
    Strange, G.
    McNeil, K.
    Williams, T. J.
    Gabbay, E.
    Proudman, S.
    Weintraub, R. G.
    Wlodarczyk, J.
    Dalton, B.
    INTERNAL MEDICINE JOURNAL, 2011, 41 (03) : 227 - 234
  • [50] Safety of long-term dupilumab treatment in adults with moderate-to-severe atopic dermatitis: results from an open-label extension trial up to 5 years
    Beck, Lisa A.
    Bissonnette, Robert
    Deleuran, Mette
    Nakahara, Takeshi
    Galus, Ryszard
    Khokhar, Faisal A.
    Coleman, Anna
    Gherardi, Guy
    Xiao, Jing
    Dingman, Robert
    Xu, Christine
    Avetisova, Elena
    Dubost-Brama, Ariane
    Shabbir, Arsalan
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
12345